Tiziana Life Sciences Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.24

-0.01 (-0.80%)

As of Mar 29, 10:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,959.7% upside

Low Target $25.58

Average Target $37.94

High Target $45.71

Current Price $1.24

Current
$1.24

Target
$37.94

$25.58 $37.94 avg $45.71

Scenario Analysis

Bear Case

$25.58

1,962.9%

Low target

Base Case

$37.94

+2,959.7%

Avg target

Bull Case

$45.71

+3,586.3%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$2.60

-52.3% from high

52-Week Low

$0.73

+69.9% from low

Target vs 52W High

$37.94

+1,359.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%